Your session is about to expire
← Back to Search
Artificial Intelligence
AI-Powered Medication Adherence App for First Episode Psychosis
Phase 4
Recruiting
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Prescribed an oral antipsychotic
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial aims to test whether an AI smartphone app can help patients with first episode psychosis stick to their medication regimen.
Who is the study for?
This trial is for individuals enrolled in a Coordinated Specialty Care (CSC) program who have been prescribed an oral antipsychotic medication to manage conditions like psychosis or first episode psychosis. There are no specific exclusion criteria, so it's open to anyone meeting the inclusion requirements.Check my eligibility
What is being tested?
The study is testing an artificial intelligence-powered smartphone app designed to help patients with their adherence to taking oral antipsychotic medications regularly as compared to the usual care without such technological support.See study design
What are the potential side effects?
Since this trial involves using a smartphone app rather than a drug, there aren't typical medical side effects. However, participants may experience issues related to privacy, data security, or stress from technology use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am taking an oral antipsychotic medication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Service Utilization Report Form
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smartphone AppExperimental Treatment1 Intervention
artificial intelligence (AI) smartphone app to provide support for medication adherence
Group II: Usual CareActive Control1 Intervention
Usual care provided at CSC clinic
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,812 Previous Clinical Trials
2,667,474 Total Patients Enrolled
Northwell HealthLead Sponsor
461 Previous Clinical Trials
470,935 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I am taking an oral antipsychotic medication.
Research Study Groups:
This trial has the following groups:- Group 1: Smartphone App
- Group 2: Usual Care
Awards:
This trial has 3 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger